4D Molecular Therapeutics (FDMT) Asset Utilization Ratio (2021 - 2026)
4D Molecular Therapeutics' (FDMT) Asset Utilization Ratio came in at 0.18 for Q2 2026, compared with 0.00 a year earlier and up 12.0% from the prior quarter.
Powered by 
Analysis
4D Molecular Therapeutics (FDMT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
For FY2025, 4D Molecular Therapeutics' Asset Utilization Ratio stood at 0.15.
- In prior years, 4D Molecular Therapeutics' Asset Utilization Ratio was 0.00 in FY2024 (-99.9%), 0.07 in FY2023 (+577.3%), 0.01 in FY2022 (-81.9%) and 0.06 in FY2021 (-28.4%).
- The Q2 2026 figure stands as the highest quarterly Asset Utilization Ratio in data going back to Q1 2021.
- On a year-over-year basis, Asset Utilization Ratio increased in 1 of the last five quarters, with growth averaging 92.6%.
- The strongest year-over-year quarter for Asset Utilization Ratio in the past five years was Q3 2025, with growth of 862.7%; the weakest was Q3 2024, with a decline of 100.0%.
- According to Business Quant data, Asset Utilization Ratio for the three prior quarters was 0.16 (Q1 2026), 0.17 (Q4 2025) and 0.00 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.44 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 0.47 |
| 10 | 4D Molecular Therapeutics | 1.02 Bn | -436.78 Mn | - | 0.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.18 |
| Mar 31, 2026 | 0.16 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.03 |
| Mar 31, 2024 | 0.04 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.05 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.07 |
API Access
4D Molecular Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=FDMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "FDMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=FDMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();